These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 32249346)

  • 1. Toxicokinetics and toxicodynamics of the fentanyl homologs cyclopropanoyl-1-benzyl-4´-fluoro-4-anilinopiperidine and furanoyl-1-benzyl-4-anilinopiperidine.
    Gampfer TM; Wagmann L; Park YM; Cannaert A; Herrmann J; Fischmann S; Westphal F; Müller R; Stove CP; Meyer MR
    Arch Toxicol; 2020 Jun; 94(6):2009-2025. PubMed ID: 32249346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxicokinetic Studies and Analytical Toxicology of the New Synthetic Opioids Cyclopentanoyl-Fentanyl and Tetrahydrofuranoyl-Fentanyl.
    Gampfer TM; Wagmann L; Richter MJ; Fischmann S; Westphal F; Meyer MR
    J Anal Toxicol; 2020 Apr; 44(5):449-460. PubMed ID: 32020187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicokinetics and analytical toxicology of the abused opioid U-48800 - in vitro metabolism, metabolic stability, isozyme mapping, and plasma protein binding.
    Gampfer TM; Richter LHJ; Schäper J; Wagmann L; Meyer MR
    Drug Test Anal; 2019 Oct; 11(10):1572-1580. PubMed ID: 31424163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the metabolism of the fentanyl-derived designer drug butyrfentanyl in human in vitro liver preparations and authentic human samples using liquid chromatography-high resolution mass spectrometry (LC-HRMS).
    Steuer AE; Williner E; Staeheli SN; Kraemer T
    Drug Test Anal; 2017 Jul; 9(7):1085-1092. PubMed ID: 27736030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to Study the Metabolism of New Psychoactive Substances for the Purpose of Toxicological Screenings-A Follow-Up Study Comparing Pooled Human Liver S9, HepaRG Cells, and Zebrafish Larvae.
    Wagmann L; Frankenfeld F; Park YM; Herrmann J; Fischmann S; Westphal F; Müller R; Flockerzi V; Meyer MR
    Front Chem; 2020; 8():539. PubMed ID: 32766204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zebrafish early life stages as alternative model to study 'designer drugs': Concordance with mammals in response to opioids.
    Kirla KT; Erhart C; Groh KJ; Stadnicka-Michalak J; Eggen RIL; Schirmer K; Kraemer T
    Toxicol Appl Pharmacol; 2021 May; 419():115483. PubMed ID: 33722667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Qualitative studies on the metabolism and the toxicological detection of the fentanyl-derived designer drugs 3-methylfentanyl and isofentanyl in rats using liquid chromatography-linear ion trap-mass spectrometry (LC-MS(n)).
    Meyer MR; Dinger J; Schwaninger AE; Wissenbach DK; Zapp J; Fritschi G; Maurer HH
    Anal Bioanal Chem; 2012 Jan; 402(3):1249-55. PubMed ID: 22065349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and cytotoxicity studies of the two hallucinogens 1cP-LSD and 4-AcO-DET in human liver and zebrafish larvae models using LC-HRMS/MS and a high-content screening assay.
    Gampfer TM; Schütz V; Schippers P; Rasheed S; Baumann J; Wagmann L; Pulver B; Westphal F; Flockerzi V; Müller R; Meyer MR
    J Pharm Biomed Anal; 2024 Aug; 245():116187. PubMed ID: 38692215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicokinetics and Analytical Toxicology of Flualprazolam: Metabolic Fate, Isozyme Mapping, Human Plasma Concentration and Main Urinary Excretion Products.
    Wagmann L; Manier SK; Bambauer TP; Felske C; Eckstein N; Flockerzi V; Meyer MR
    J Anal Toxicol; 2020 Jul; 44(6):549-558. PubMed ID: 32104896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro Characterization of NPS Metabolites Produced by Human Liver Microsomes and the HepaRG Cell Line Using Liquid Chromatographyhigh Resolution Mass Spectrometry (LC-HRMS) Analysis: Application to Furanyl Fentanyl.
    Richeval C; Gicquel T; Hugbart C; Le Dare B; Allorge D; Morel I; Gaulier JM
    Curr Pharm Biotechnol; 2017; 18(10):806-814. PubMed ID: 29173157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of the active metabolite of quetiapine, N-desalkylquetiapine in vitro.
    Bakken GV; Molden E; Knutsen K; Lunder N; Hermann M
    Drug Metab Dispos; 2012 Sep; 40(9):1778-84. PubMed ID: 22688609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of human liver cytochrome P-450 3A4 as the enzyme responsible for fentanyl and sufentanil N-dealkylation.
    Tateishi T; Krivoruk Y; Ueng YF; Wood AJ; Guengerich FP; Wood M
    Anesth Analg; 1996 Jan; 82(1):167-72. PubMed ID: 8712396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In Vitro Metabolism and Hepatic Intrinsic Clearance of the Synthetic Cannabinoid Receptor Agonist JWH-122 and Its Four ω-Halogenated Analogues.
    Davidsen AB; Mardal M; Linnet K
    AAPS J; 2019 May; 21(4):63. PubMed ID: 31093790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism of fentanyl, a synthetic opioid analgesic, by human liver microsomes. Role of CYP3A4.
    Feierman DE; Lasker JM
    Drug Metab Dispos; 1996 Sep; 24(9):932-9. PubMed ID: 8886601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro metabolism of the novel synthetic opioid agonist cyclopropylfentanyl and subsequent confirmation in authentic human samples using liquid chromatography-high resolution mass spectrometry.
    Cutler C; Hudson S
    Drug Test Anal; 2019 Aug; 11(8):1134-1143. PubMed ID: 31081594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro functional characterization of a panel of non-fentanyl opioid new psychoactive substances.
    Vandeputte MM; Cannaert A; Stove CP
    Arch Toxicol; 2020 Nov; 94(11):3819-3830. PubMed ID: 32734307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenethylamine-derived new psychoactive substances 2C-E-FLY, 2C-EF-FLY, and 2C-T-7-FLY: Investigations on their metabolic fate including isoenzyme activities and their toxicological detectability in urine screenings.
    Wagmann L; Hempel N; Richter LHJ; Brandt SD; Stratford A; Meyer MR
    Drug Test Anal; 2019 Oct; 11(10):1507-1521. PubMed ID: 31299701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the biotransformation pathways of clomiphene, tamoxifen and toremifene as assessed by LC-MS/(MS) following in vitro and excretion studies.
    Mazzarino M; Biava M; de la Torre X; Fiacco I; Botrè F
    Anal Bioanal Chem; 2013 Jun; 405(16):5467-87. PubMed ID: 23604525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flubromazolam-Derived Designer Benzodiazepines: Toxicokinetics and Analytical Toxicology of Clobromazolam and Bromazolam.
    Wagmann L; Manier SK; Felske C; Gampfer TM; Richter MJ; Eckstein N; Meyer MR
    J Anal Toxicol; 2021 Nov; 45(9):1014-1027. PubMed ID: 33048135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic fate of the new synthetic cannabinoid 7'N-5F-ADB in rat, human, and pooled human S9 studied by means of hyphenated high-resolution mass spectrometry.
    Richter LHJ; Maurer HH; Meyer MR
    Drug Test Anal; 2019 Feb; 11(2):305-317. PubMed ID: 30160067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.